Mimedx Group Inc’s recent filing unveils that its General Counsel and CAO Hulse William Frank IV unloaded Company’s shares for reported $0.16 million on Mar 13 ’24. In the deal valued at $7.95 per share,20,381 shares were sold. As a result of this transaction, Hulse William Frank IV now holds 479,959 shares worth roughly $2.99 million.
Then, Whitlow Ricci S sold 15,271 shares, generating $122,351 in total proceeds. Upon selling the shares at $8.01, the Chief Operating Officer now owns 401,050 shares.
Before that, Whitlow Ricci S sold 15,493 shares. Mimedx Group Inc shares valued at $125,075 were divested by the Chief Operating Officer at a price of $8.07 per share. As a result of the transaction, Whitlow Ricci S now holds 416,321 shares, worth roughly $2.59 million.
Lake Street initiated its Mimedx Group Inc [MDXG] rating to a Buy in a research note published on March 07, 2024; the price target was $12. A number of analysts have revised their coverage, including Craig Hallum’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. Mizuho began covering MDXG with “Buy” recommendation on October 13, 2022. Northland Capital started covering the stock on July 26, 2021. It rated MDXG as “an Outperform”.
Price Performance Review of MDXG
On Tuesday, Mimedx Group Inc [NASDAQ:MDXG] saw its stock fall -1.89% to $6.23. Over the last five days, the stock has lost -11.25%. Mimedx Group Inc shares have fallen nearly -28.96% since the year began. Nevertheless, the stocks have risen 88.22% over the past one year. While a 52-week high of $9.27 was reached on 02/29/24, a 52-week low of $3.31 was recorded on 04/16/24. SMA at 50 days reached $7.73, while 200 days put it at $7.54. A total of 0.49 million shares were traded, compared to the trading of 0.5 million shares in the previous session.
Levels Of Support And Resistance For MDXG Stock
The 24-hour chart illustrates a support level at 6.16, which if violated will result in even more drops to 6.10. On the upside, there is a resistance level at 6.32. A further resistance level may holdings at 6.42. The Relative Strength Index (RSI) on the 14-day chart is 23.94, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.57, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.55%. Stochastics %K at 1.99% indicates the stock is a buying.
The most recent change occurred on March 19, 2021 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $20 price target.
